Direct Meds GLP-1 vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Direct Meds GLP-1 scores higher on our rubric, 7.9/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Direct Meds GLP-1 - our pick of these two →or find your match

Direct Meds GLP-1 beats MEDVi overall, scoring 7.9/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: Direct Meds GLP-1 is from $297/mo; MEDVi is $179 first month, then $299/mo. Choose Direct Meds GLP-1 for users who value published format-specific pricing and can independently monitor billing and cancellation. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.

A side-by-side look at Direct Meds GLP-1 and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Direct Meds GLP-1

#8 of 54

7.9/10

Compounded GLP-1 program with published format-specific prices, offset by a sharply negative BBB complaint record around billing, cancellation, and fulfillment.

Visit Direct Meds GLP-1

MEDVi

#46 of 54

5.7/10

MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.

Visit MEDVi

Feature	Direct Meds GLP-1	MEDVi
Why each one	Thorough clinical consultations focused on medical-grade patient experience rather than quick-turnaround prescribing.	Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication.
Our Score	7.9/10	5.7/10
Headline Price	from $297/mo	$179 first month, then $299/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	Users who value published format-specific pricing and can independently monitor billing and cancellation	Users who want both oral and injectable compounded options in one telehealth program
Watch out for	Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu	FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
Ranking	#8	#46
Get started	Visit Direct Meds GLP-1	Visit MEDVi

Pros & Cons Compared

Direct Meds GLP-1

Pros

+The published $297/mo compounded semaglutide injection tier includes medication, consultations, shipping, and pharmacy fees
+Format-specific prices are published on the site, which makes the advertised medication and service bundle easier to compare
+Fast pharmacy fulfillment: most orders ship within 48 hours of provider approval
+Responsive customer support with live chat available during business hours

Cons

−Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu
−The $297/mo injectable semaglutide rate sits above Henry Meds ($199) and TrimRx (starting at $179); Direct Meds' own sublingual semaglutide drops at $179 are the budget path if the premium stings
−BBB shows 248 complaints and roughly 1.1/5 customer-review stars, with recurring reports of unauthorized charges, cancellation difficulty, billing confusion, and unfulfilled or delayed orders

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping

Cons

−FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
−Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
−The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
−Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

Direct Meds GLP-1 edges out MEDVi with a score of 7.9/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: Direct Meds GLP-1 is from $297/mo; MEDVi is $179 first month, then $299/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility.